A phase II study of hydrocodone for cough in advanced cancer
Authors:
- 1 January 2002
- journal article
- clinical trial
- Published by SAGE Publications in American Journal of Hospice and Palliative Medicine®
- Vol. 19 (1) , 49-56
Abstract
Purpose: Cough is a common symptom in advanced cancer. The use of hydrocodone as an antitussive has not been studied previously in this setting. This study evaluates hydrocodone for cough in advanced cancer. Methods: The results presented are from a phase II study with dose titration. Setting: Palliative medicine program in a tertiary referral center. Patients: 25 consecutive patients with cough from irreversible causes, on a stable opioid regimen for the prior 24 hours, and no previous or current use of hydrocodone for cough. Intervention: 5 mg hydrocodone was administered twice daily. The dose was then titrated daily (maximum: 60 mg/24 h), if needed, until a 3 50 percent improvement of the frequency of cough was achieved and then maintained for three consecutive days. Measurements: Cough severity, frequency, complications, and hydrocodone side effects. Results: 20 persons (10 women and 10 men) completed study evaluation. Median age was 63 years (range: 42-82). Nine patients had lung cancer and seven had lung or pleura metastases; 19 patients had at least 50 percent improvement of their cough frequency. The median best response was 70 percent improvement in the cough frequency (range: 50-90 percent). Median hydrocodone dose associated with the best response was 10 mg/day (range: 5-30 mg/day). Cough severity, frequency, associated symptoms and complications, and activities of daily living improved significantly. Side effects of hydrocodone (dry mouth, nausea, and drowsiness) were tolerable and rated as mild. Conclusions: Hydrocodone is effective and safe to treat cough in advanced cancer. A starting dose of 10 mg per day in divided doses seems effective. Dose escalation may be required. Most improved within one day.Keywords
This publication has 12 references indexed in Scilit:
- Hydrocodone for cough in advanced cancerAmerican Journal of Hospice and Palliative Medicine®, 2000
- The symptoms of advanced cancer: relationship to age, gender, and performance status in 1,000 patientsSupportive Care in Cancer, 2000
- Contributing Factors to Physical Symptoms in Terminally-Ill Cancer PatientsJournal of Pain and Symptom Management, 1999
- Efficacy and safety of levodropropizine and dihydrocodeine on nonproductive cough in primary and metastatic lung cancerEuropean Respiratory Journal, 1998
- Cancer statistics, 1998CA: A Cancer Journal for Clinicians, 1998
- Benzonatate for opioid-resistant cough in advanced cancerPalliative Medicine, 1998
- Symptoms of lung cancerPalliative Medicine, 1992
- Hydrocodone versus codeine in acute musculoskeletal painAnnals of Emergency Medicine, 1991
- Symptoms of pancreatic cancerJournal of Pain and Symptom Management, 1991
- Peripheral opioid receptors and the cough reflexRespiratory Medicine, 1991